Patents
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
07/1999
07/21/1999EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them
07/21/1999EP0929217A1 Sordarin derivatives
07/21/1999CN1223592A Fluoro labelled anthracyclinone and anthracycline derivatives
07/21/1999CN1044240C Tetrahydro-pyrene compound and nematicide against pine wood nematodes containing the same
07/20/1999US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups
07/15/1999WO1999034793A1 Pyronin antibacterials, process and novel intermediates thereto
07/15/1999WO1999025716A3 Pyranones, method for the production and use thereof
07/15/1999CA2315156A1 Pyronin antibacterials, process and novel intermediates thereto
07/08/1999WO1999033782A1 Anticancer platinum (iv) complexes for oral administration
07/06/1999US5919950 Squarylium compounds, and processes and intermediates for the synthesis of these compounds
07/06/1999US5919819 Dihydropyran derivatives as viral neuraminidase inhibitors
07/01/1999WO1999032468A1 Anilide derivative, production and use thereof
07/01/1999WO1999032225A2 Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates
07/01/1999WO1999032100A2 Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative
07/01/1999CA2311428A1 Anilide derivative, production and use thereof
07/01/1999CA2309661A1 Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates
07/01/1999CA2304959A1 Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative
06/1999
06/30/1999EP0925786A1 Remedies for ischemic diseases
06/29/1999US5917061 Process for producing cyclic ethers by liquid phase reaction
06/29/1999US5917058 Treating open ring hydroxy acid form of the statin with acetic acid in the absence of a strong acid catalyst and in the presence of an antisolvent
06/29/1999US5916975 Reacting a prochiral olefin with sodium hypochlorite a source of oxygen in presence of salen catalyst and isoquinoline n-oxide compound as electron donar ligand; epoxidation
06/29/1999US5916784 Oxidizing a glucamine with oxidizing microbe of species gluconobacter oxydans to produce a 6-(substituted amino)-6-deoxy-alpha-l sorbofuranose
06/24/1999WO1999031075A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/24/1999WO1999031074A2 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
06/24/1999WO1999031057A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/24/1999WO1999031037A1 Apoptosis inhibitors
06/24/1999CA2314954A1 Apoptosis inhibitors
06/22/1999US5914344 Substituted carboxanilide derivative and plant disease control agent comprising same as active ingredient
06/19/1999CA2256303A1 The use of mmp inhibitors for the treatment of ocular angiogenesis
06/17/1999WO1999029681A1 Hydroxylamine derivatives
06/09/1999EP0739403B1 Polymerizable chiral compounds and their use
06/09/1999CN1218805A Process for preparing penta or hexa cyclic ether, particularly dehydropolyol
06/03/1999WO1999026614A1 Substituted 2-aminoacetamides and the use thereof
06/01/1999US5908941 Reactin a chemical intermediate with an acid in presence of an aprotic solvent
06/01/1999US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism
06/01/1999US5908581 Fluorescent material
05/1999
05/27/1999WO1999025716A2 Pyranones, method for the production and use thereof
05/27/1999WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999WO1999025365A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
05/27/1999CA2310244A1 Pyranones, methods of preparing and using them
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/26/1999EP0917587A1 A new method for producing pravastatin precursor, ml-236b
05/26/1999EP0777663B1 Use of substituted 6-amino-4h-pyrans
05/25/1999US5907048 Reacting an aldehyde with conjugated diene in presence of lewis acid catalyst and a co-catalyst selected from a base and a compound such as an ester, chloro-acetic ester, ether, ketone, carbonate, capable of dissolving lewis acid
05/20/1999WO1999024437A1 Novel substituted phenyl keto enols
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024386A1 Prins reaction products of 5,7-dimethyl-oct-6-en-2-one and their use as fragrance materials
05/20/1999WO1999024030A1 Novel trienyl compounds
05/20/1999WO1998023574A8 Asiatic acid derivatives and medicines for treating wounds, which contains the same
05/20/1999DE19751200A1 New epothilone derivatives
05/20/1999DE19750623A1 New 2H-1-pyran-2-one derivatives useful as anticonvulsants and neuroprotectants
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/19/1999EP0916664A1 Enynes used in the synthesis of antifungal agents
05/19/1999EP0915846A2 2- and 2,5-substituted phenylketoenols
05/19/1999EP0915825A2 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
05/19/1999CN1043425C Sub-salicylic amino transition metal compounding agent and it mfg. method
05/18/1999CA2109744C 1-phenylbicyclo¬2.2.2|octane derivatives, a process for their preparation and pharmaceutical compositions holding same
05/14/1999WO1999023089A1 Recovery of gamma-pyrones
05/14/1999WO1999023088A1 Vinyl ether derivatives
05/14/1999WO1999023063A1 Substituted anilides
05/14/1999WO1999007692A3 New epothilone derivatives, method for producing same and their pharmaceutical use
05/14/1999WO1999001423A8 Glucagon antagonists/inverse agonists
05/12/1999EP0915091A2 Process of preparation of five- or sixmembered cyclic ethers, in particular anhydropolyols
05/12/1999EP0654037B1 Antiretroviral enantiomeric nucleotide analogs
05/12/1999DE19749720A1 Neue substituierte Phenylketoenole New substituted Phenylketoenole
05/06/1999WO1999021816A1 Novel liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element
05/06/1999EP0912655A1 Liquid crystalline saccharose derivatives
05/06/1999DE19749717A1 New epothilone derivatives
05/04/1999US5900415 Dietetic and cardiovascular disorders
05/04/1999CA2074641C Method of treating ocular inflammation
04/1999
04/29/1999DE19748928A1 New epothilone derivatives
04/28/1999EP0910415A1 Fluoro labelled anthracyclinone and anthracycline derivatives
04/28/1999CN1215390A Substituted phenyl keto enols as pesticides and herbicides
04/27/1999CA2100800C Process for the production of 6e-leucotriene b4 and intermediary products of the said production process
04/22/1999WO1999019318A1 Chromone compounds and use thereof
04/22/1999WO1999019296A1 Aminobutanoic acid derivatives
04/22/1999WO1999006361A3 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
04/22/1999WO1999002146A8 Amino acid derivatives
04/22/1999DE19745442A1 Production of lactones from cyclic ketones using organic acid ion exchanger as a solid catalyst for liquid phase oxidation, for use as fiber precursors
04/06/1999US5892113 Protease inhibitors
04/06/1999US5892059 Process for producing a rose oxide
04/06/1999US5891862 Polyvalent polymers for the treatment of rotavirus infection
04/01/1999WO1999015487A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia
04/01/1999CA2304274A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia
03/1999
03/31/1999EP0637298B1 Substituted cyclohexene-1,2-bicarboxylic acid derivatives and raw materials for producing them
03/30/1999CA2144313C 4-hydroxy-2-cyclopentenone derivative and carcinostatic and osteogenesis promoter containing the same
03/25/1999WO1999014211A1 α-PYRONES FOR TREATING α-PYRONE RESPONSIVE STATES
03/25/1999WO1999014210A1 Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
03/25/1999WO1999014185A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/25/1999DE19741400A1 New benzyl-biphenyl derivatives
03/25/1999CA2303323A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments
03/23/1999US5886242 Dopes for nematic or cholesteric liquid crystals in order to produce layers which reflect in colors; comprising a polyvalent chiral group, at least one unsaturated group, at least one spacer and at least one mesogenic polyvalent chiral
03/23/1999US5886240 Process for preparing aromatic acetylenes using palladacycles as catalysts
03/18/1999WO1999012919A1 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
03/17/1999EP0901498A2 Method for synthesizing c-glycosides of ulosonic acids
03/17/1999EP0901493A1 Process for the preparation of an indacene compound
03/16/1999US5883251 Enzyme inhibitors
03/16/1999US5883106 5-lipoxygenase inhibitors
03/16/1999US5883096 Di-n-substituted piperazine derivatives; alzheimer*s disease, cognition activators; synergistic mixtures with acetylcholinesterase inhibitors
03/16/1999CA1340452C Novel hmg-coa reductase inhibitors
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 129